Mitochondrial Calcium Regulation of Cardiac Metabolism in Health and Disease
Physiology · 01.09.2024 · 39 (5) · 247-268
DOI: 10.1152/physiol.00014.2024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Physiology, erschienen am 01.09.2024. Verfasst von Enrique Balderas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, Utah, United States. Hauptthemen laut MEDLINE: Calcium, Mitochondria, Heart. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Nora Eccles Treadwell Foundation.
Abstract (Originalsprache)
Oxidative phosphorylation is regulated by mitochondrial calcium (Ca 2+ ) in health and disease. In physiological states, Ca 2+ enters via the mitochondrial Ca 2+ uniporter and rapidly enhances NADH and ATP production. However, maintaining Ca 2+ homeostasis is critical: insufficient Ca 2+ impairs stress adaptation, and Ca 2+ overload can trigger cell death. In this review, we delve into recent insights further defining the relationship between mitochondrial Ca 2+ dynamics and oxidative phosphorylation. Our focus is on how such regulation affects cardiac function in health and disease, including heart failure, ischemia-reperfusion, arrhythmias, catecholaminergic polymorphic ventricular tachycardia, mitochondrial cardiomyopathies, Barth syndrome, and Friedreich’s ataxia. Several themes emerge from recent data. First, mitochondrial Ca 2+ regulation is critical for fuel substrate selection, metabolite import, and matching of ATP supply to demand. Second, mitochondrial Ca 2+ regulates both the production and response to reactive oxygen species (ROS), and the balance between its pro- and antioxidant effects is key to how it contributes to physiological and pathological states. Third, Ca 2+ exerts localized effects on the electron transport chain (ETC), not through traditional allosteric mechanisms but rather indirectly. These effects hinge on specific transporters, such as the uniporter or the Na + /Ca 2+ exchanger, and may not be noticeable acutely, contributing differently to phenotypes depending on whether Ca 2+ transporters are acutely or chronically modified. Perturbations in these novel relationships during disease states may either serve as compensatory mechanisms or exacerbate impairments in oxidative phosphorylation. Consequently, targeting mitochondrial Ca 2+ holds promise as a therapeutic strategy for a variety of cardiac diseases characterized by contractile failure or arrhythmias.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, Utah, United States.
- Division of Cardiovascular Medicine, Department of Internal Medicine, Biochemistry, Biomedical Engineering, University of Utah, Salt Lake City, Utah, United States.
ORCID-Profile: Enrique Balderas, Dipayan Chaudhuri
Förderung
- NHLBI NIH HHS
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- Nora Eccles Treadwell Foundation
Zitieren
APA
Balderas, E., Lee, S. H. J., Rai, N. K., Mollinedo, D. M., Duron, H. E., & Chaudhuri, D. (2024). Mitochondrial Calcium Regulation of Cardiac Metabolism in Health and Disease. Physiology, 39(5), 247-268. https://doi.org/10.1152/physiol.00014.2024
Vancouver
Balderas E, Lee SHJ, Rai NK, Mollinedo DM, Duron HE, Chaudhuri D. Mitochondrial Calcium Regulation of Cardiac Metabolism in Health and Disease. Physiology. 2024;39(5):247-268. doi:10.1152/physiol.00014.2024
BibTeX
@article{Balderas2024,
author = {Balderas, Enrique and Lee, Sandra H J and Rai, Neeraj K and Mollinedo, David M and Duron, Hannah E and Chaudhuri, Dipayan},
title = {Mitochondrial Calcium Regulation of Cardiac Metabolism in Health and Disease},
journal = {Physiology},
year = {2024},
volume = {39},
number = {5},
pages = {247--268},
doi = {10.1152/physiol.00014.2024}
}
EUVIMED